Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis

Scandinavian Journal of Infectious Diseases
Marcin KłakTao Jin

Abstract

Haemostatic balance shifts towards pro-coagulation during infection. Plasminogen, a key molecule of fibrinolysis, may play an important role in the pathogenesis of staphylococcal infections. In the present study, we assessed the impact of inhibition of plasminogen activation by tranexamic acid on the course of staphylococcal sepsis and septic arthritis in mice. We found significantly down-regulated plasmin activity and increased D-dimer levels in the blood from the mice with staphylococcal sepsis. Treatment with tranexamic acid significantly increased the severity and mortality of staphylococcal infection. In addition, tranexamic acid reduced the survival rate in a murine model for staphylococcal enterotoxin A-induced death. The aggravation of diseases by tranexamic acid was due neither to the pro-inflammatory cytokine network, nor to impairment of bacterial clearance. Modulation of fibrinolysis, either by supplement of fibrinolytic molecules (tissue plasminogen activator or plasmin) or by fibrinogen depletion, did not reduce the mortality of staphylococcal sepsis. In conclusion, we report that treatment with tranexamic acid led to distinct aggravation of staphylococcal septic arthritis and sepsis in mice, suggesting the clinic...Continue Reading

References

Aug 1, 1991·Infection and Immunity·T BremellA Tarkowski
Nov 1, 1990·Arthritis and Rheumatism·T BremellA Tarkowski
Mar 29, 1990·The New England Journal of Medicine·P BertozziH A Chapman
Oct 1, 1988·European Journal of Immunology·M HelleL A Aarden
Jan 1, 1973·British Journal of Haematology·S SilbermanH C Kwaan
Jun 1, 1994·Infection and Immunity·T BremellA Tarkowski
Jan 1, 1993·Annual Review of Cell Biology·K J Tracey, A Cerami
Jul 13, 2004·Advances in Immunology·Christopher J CzuraKevin J Tracey
Jul 5, 2005·The Journal of Infectious Diseases·Tao JinAndrej Tarkowski
Jun 1, 2007·The New England Journal of Medicine·Pier Mannuccio Mannucci, Marcel Levi
Jul 21, 2007·The American Journal of Pathology·Haiwang TangFlorea Lupu

❮ Previous
Next ❯

Citations

Jan 13, 2015·Transfusion Medicine Reviews·Dominik F Draxler, Robert L Medcalf
Aug 9, 2016·The Journal of Arthroplasty·Qunn Jid LeeYiu Chung Wong
Oct 29, 2017·Journal of Orthopaedic Surgery and Research·Lu-Kai ZhangZheng-Rui Fan
Jul 1, 2014·Spine·Jason M CuellarThomas J Errico
Apr 21, 2021·Seminars in Thrombosis and Hemostasis·Julie Brogaard Larsen, Anne-Mette Hvas

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.